This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Amilyfe, LLC, University of Florida Research Foundation Inc.. Active years: 2025-2026.
Company Filing History:
2 out of 6 
2 out of 3,046 
Years Active: 2025-2026
Title: Shanshan Lin: Innovator in Cystic Fibrosis Treatment
Introduction
Shanshan Lin is a notable inventor based in Gainesville, FL (US). She has made significant contributions to the field of medical science, particularly in the treatment of cystic fibrosis. Her innovative work focuses on amino acid compositions that enhance the functionality of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.
Latest Patents
Shanshan Lin holds a patent for "Amino acid compositions and methods for treating cystic fibrosis." This patent describes amino acid compositions that are effective in increasing the translocation of the CFTR protein from the cytoplasm to the plasma membrane, especially in epithelial cells. The methods outlined in her patent aim to increase the concentration of CFTR in the plasma membrane, thereby enhancing chloride ion transport and water transport. These compositions are particularly useful for treating cystic fibrosis in individuals with mutations in the CFTR protein.
Career Highlights
Throughout her career, Shanshan Lin has worked with various organizations, including Amilyfe, LLC and the University of Florida Research Foundation Inc. Her work has been instrumental in advancing the understanding and treatment of cystic fibrosis.
Collaborations
Shanshan Lin has collaborated with notable colleagues such as Xiaodong Xu and Sadasivan Vidyasagar. These collaborations have contributed to her research and the development of her innovative solutions.
Conclusion
Shanshan Lin's contributions to the field of cystic fibrosis treatment through her patented innovations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments for this challenging condition.